Literature DB >> 23002382

Optimal warfarin management for the prevention of thromboembolic events in patients with atrial fibrillation: a systematic review of the clinical evidence.

.   

Abstract

Entities:  

Year:  2012        PMID： 23002382      PMCID： PMC3442618     

Source DB:  PubMed          Journal:  CADTH Technol Overv        ISSN： 1203-9012


× No keyword cloud information.
  10 in total

1.  Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).

Authors:  Jack Ansell; Jennifer Hollowell; Vittorio Pengo; Fernando Martinez-Brotons; Jaime Caro; Ludovic Drouet
Journal:  J Thromb Thrombolysis       Date:  2007-04       Impact factor: 2.300

2.  The impact of pharmacist-managed oral anticoagulation therapy in older veterans.

Authors:  I O Poon; L Lal; E N Brown; U K Braun
Journal:  J Clin Pharm Ther       Date:  2007-02       Impact factor: 2.512

Review 3.  Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis.

Authors:  Ricarda Marinigh; Gregory Y H Lip; Nicola Fiotti; Carlo Giansante; Deirdre A Lane
Journal:  J Am Coll Cardiol       Date:  2010-09-07       Impact factor: 24.094

Review 4.  Thromboembolism in atrial fibrillation.

Authors:  Jan Menke; Lars Lüthje; Andreas Kastrup; Jörg Larsen
Journal:  Am J Cardiol       Date:  2010-02-15       Impact factor: 2.778

Review 5.  Underuse of oral anticoagulants in atrial fibrillation: a systematic review.

Authors:  Isla M Ogilvie; Nick Newton; Sharon A Welner; Warren Cowell; Gregory Y H Lip
Journal:  Am J Med       Date:  2010-07       Impact factor: 4.965

6.  Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.

Authors:  John A Cairns; Stuart Connolly; Sean McMurtry; Michael Stephenson; Mario Talajic
Journal:  Can J Cardiol       Date:  2011 Jan-Feb       Impact factor: 5.223

Review 7.  Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?

Authors:  Graeme J Hankey
Journal:  Curr Opin Neurol       Date:  2010-02       Impact factor: 5.710

8.  Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Jack Ansell; Jack Hirsh; Elaine Hylek; Alan Jacobson; Mark Crowther; Gualtiero Palareti
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.

Authors:  Irina Savelieva; Abhay Bajpai; A John Camm
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

Review 10.  Outpatient management of anticoagulation therapy.

Authors:  Anne L du Breuil; Elena M Umland
Journal:  Am Fam Physician       Date:  2007-04-01       Impact factor: 3.292
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.